Paradoxical response to tacrolimus assessed by interleukin-2 gene expression.

Transplant Proc

Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London, London, United Kingdom.

Published: December 2006

Background: The calcineurin inhibitors cyclosporine and tacrolimus are potent immunosuppressive drugs, used mainly after organ transplantation. Methods to monitor their pharmacodynamic effects are not well established.

Methods: Whole blood samples from healthy volunteers (n = 16) were incubated for 24 hours in culture medium; each sample was preincubated for 2 hours with or without tacrolimus. An identical procedure was performed for 7 samples using blood from renal transplant patients before transplantation. Following the culture period, total RNA was isolated and quantitative reverse transcriptase polymerase chain reaction, using TaqMan probes, was employed to quantify interleukin-2 (IL-2) mRNA expression, and IL-2 mRNA copy number was reported by reference to a standard curve.

Results: IL-2 mRNA synthesis was suppressed by the presence of tacrolimus in most cases, compared with a control sample. However, some samples demonstrated up-regulation of mRNA expression. In the patient samples, there was up-regulation of IL-2 mRNA in two samples and, after transplantation, these patients developed acute rejection.

Conclusion: Quantitative measurement of cytokine IL-2 regulated gene expression may represent a method to assess the efficacy of calcineurin inhibitor drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2006.10.181DOI Listing

Publication Analysis

Top Keywords

il-2 mrna
16
gene expression
8
mrna expression
8
samples
5
il-2
5
mrna
5
paradoxical response
4
tacrolimus
4
response tacrolimus
4
tacrolimus assessed
4

Similar Publications

Background: Renal failure related death caused by diabetic kidney disease (DKD) is an inevitable outcome for most patients. This study aimed to identify the critical genes involved in the onset and progression of DKD and to explore potential therapeutic targets of DKD.

Methods: We conducted a batch of protein quantitative trait loci (pQTL) Mendelian randomization analysis to obtain a group of proteins with causal relationships with DKD and then identified key proteins through colocalization analysis to determine correlations between variant proteins and disease outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • TILT-123, an oncolytic virus engineered to enhance T-cell responses, was tested in the TUNIMO trial on 20 patients with advanced solid tumors to evaluate its safety, efficacy, and immunological effects.
  • The study found that a greater decrease in blood lymphocyte count after treatment was associated with better tumor response and longer overall survival, which was corroborated by an external dataset of 96 patients.
  • Analysis of tumor biopsies revealed an increase in immune cells, specifically CD8+ T cells, CD4+ T cells, and NK cells, suggesting that TILT-123 activates the immune response effectively in patients.
View Article and Find Full Text PDF

Objectives: Diabetes mellitus is a chronic disease that has become more prevalent worldwide because of lifestyle changes. It leads to serious complications, including increased atherosclerosis, protein glycosylation, endothelial dysfunction, and vascular denervation. These complications impair neovascularization and wound healing, resulting in delayed recovery from injuries and an elevated risk of infections.

View Article and Find Full Text PDF

Objective: The aim of this prospective cohort study is to analyse the humoral and cellular vaccine responses in paediatric heart transplant recipients (HTR, n = 12), and compare it with the response in healthy controls (HC, n = 14). All participants were 5-18 years old and vaccinated with mRNA vaccine against SARS-CoV-2 between December 2021 and May 2022.

Methods: The humoral response was measured by quantifying antibody titers against SARS-CoV-2 spike protein (anti-S).

View Article and Find Full Text PDF

A microglial kinase ITK mediating neuroinflammation and behavioral deficits in traumatic brain injury.

Mol Cell Neurosci

January 2025

Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea; BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea; Brain Science & Engineering Institute, Kyungpook National University, Daegu, Republic of Korea. Electronic address:

Microglia-mediated neuroinflammation has been implicated in the neuropathology of traumatic brain injuries (TBI). Recently, the expression of interleukin-2-inducible T-cell kinase (ITK) has been detected in brain microglia, regulating their inflammatory activities. However, the role of microglial ITK in TBI has not been investigated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!